Management of Subsequent Pregnancy After Prior Painless Second-Trimester Loss
Serial transvaginal ultrasound monitoring starting at 14-16 weeks is the recommended approach, with ultrasound-indicated cerclage placement only if the cervix shortens to ≤25 mm before 24 weeks of gestation. 1
Why Serial Ultrasound Is the Correct Answer (Option D)
This patient has one prior painless second-trimester loss at 18 weeks, which represents a classic presentation of possible cervical insufficiency. However, a single loss does not meet criteria for prophylactic (history-indicated) cerclage. 1, 2
The Evidence-Based Algorithm
Step 1: Begin serial cervical length monitoring
- Start transvaginal ultrasound assessment at 14-16 weeks of gestation 1
- Continue monitoring through 24 weeks 1
- Approximately 69% of high-risk women maintain cervical length >25 mm and never require cerclage 1
Step 2: Intervene based on objective cervical shortening
- If cervical length measures ≤25 mm before 24 weeks: offer ultrasound-indicated cerclage 1
- If cervical length is ≤20 mm: prescribe vaginal progesterone 200 mg daily (GRADE 1A recommendation) 1
- If cervical length is 21-25 mm: consider vaginal progesterone through shared decision-making (GRADE 1B recommendation) 1
- If cervical length is <10 mm: cerclage shows particular benefit, with decreased preterm birth at <35 weeks (39.5% vs 58.0%) 1, 2
Why the Other Options Are Incorrect
Option A (Reassurance) is inadequate:
- This patient has a documented history of painless second-trimester loss, placing her at increased risk for recurrence 3
- Simply reassuring without objective monitoring ignores established risk factors 1
Option B (Cerclage at 13 weeks) is not indicated:
- History-indicated cerclage at 12-14 weeks should be reserved for patients with three or more second-trimester pregnancy losses or extreme premature deliveries 1, 2
- This patient has only one prior loss, which does not meet threshold for prophylactic cerclage 1
- Placing cerclage at arbitrary gestational ages without objective cervical assessment is explicitly discouraged 1
Option C (Cerclage at 15 weeks) is similarly not indicated:
- The same reasoning applies—cerclage should not be placed at predetermined gestational ages without documented cervical shortening 1
- Cerclage placement must be guided by objective cervical shortening, not performed prophylactically 1
Critical Distinction: Cervical Insufficiency vs. Short Cervix
This case illustrates the important difference between these two entities:
- Cervical insufficiency is a clinical diagnosis based on history of painless cervical dilation leading to second-trimester loss 3
- Short cervix is an ultrasound finding (≤25 mm) that predicts preterm birth risk 3
- Most patients with short cervix do not have classic historical features of cervical insufficiency 3
Additional Management Considerations
If cerclage becomes indicated during monitoring:
- Consider adding vaginal progesterone 200 mg daily after cerclage placement, which may reduce spontaneous preterm birth at <34 weeks (2.2% vs 18.4%) and <37 weeks (9.1% vs 29.7%) 1, 2
Avoid these common pitfalls:
- Do not place cerclage based solely on history of one prior loss without objective cervical assessment 1
- Clinical cervical examination alone is insufficient—transvaginal ultrasound provides superior risk stratification 1
- Do not use 17-alpha hydroxyprogesterone caproate for short cervix treatment (GRADE 1B recommendation against) 4, 1
- Do not place cervical pessary due to conflicting trial data and recent safety signals (GRADE 1B recommendation against) 4, 1
Activity recommendations: